TrialThe lancet. Gastroenterology & hepatology2022

Safety and efficacy of sofosbuvir-velpatasvir to treat chronic hepatitis C virus infection in treatment-naive patients in Rwanda (SHARED-3): a single-arm trial.

Fredrick Kateera et al.PubMed ↗Publisher ↗

No numbers read from the abstract.